HealthCare Global Enterprises Limited (HCG.NS)
INR 532.3
(-1.64%)
INR 532.3
(-1.64%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 3.5 Billion INR | 11.25% |
| 2022 | 3.05 Billion INR | 36.56% |
| 2021 | 3.41 Billion INR | 88.39% |
| 2020 | 474.52 Million INR | -22.21% |
| 2019 | 1.69 Billion INR | 51.98% |
| 2018 | 1.09 Billion INR | -23.74% |
| 2017 | 1.4 Billion INR | 22.88% |
| 2016 | 1.14 Billion INR | 23.76% |
| 2015 | 809.44 Million INR | 11.56% |
| 2014 | 746.18 Million INR | 103.44% |
| 2013 | 389.55 Million INR | -16.46% |
| 2012 | 486.07 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 900.2 Million INR | -1.25% |
| 2023 Q1 | 770.8 Million INR | -4.79% |
| 2023 Q3 | 846.8 Million INR | -3.79% |
| 2023 Q4 | 971.4 Million INR | 14.71% |
| 2023 FY | - INR | 11.25% |
| 2023 Q2 | 880.2 Million INR | 14.19% |
| 2022 Q1 | 750.7 Million INR | 65.72% |
| 2022 FY | - INR | 36.56% |
| 2022 Q4 | 809.6 Million INR | 2.29% |
| 2022 Q3 | 791.5 Million INR | 3.25% |
| 2022 Q2 | 766.6 Million INR | 2.12% |
| 2021 Q2 | 630.4 Million INR | 14.12% |
| 2021 Q4 | 452.98 Million INR | -30.06% |
| 2021 Q3 | 647.7 Million INR | 2.74% |
| 2021 FY | - INR | 88.39% |
| 2021 Q1 | 552.4 Million INR | 143.65% |
| 2020 Q1 | 201.7 Million INR | -11.52% |
| 2020 Q2 | 344.7 Million INR | 70.9% |
| 2020 Q3 | 439 Million INR | 27.36% |
| 2020 Q4 | 226.72 Million INR | -48.36% |
| 2020 FY | - INR | -22.21% |
| 2019 Q3 | 459.7 Million INR | 8.91% |
| 2019 Q2 | 422.1 Million INR | -0.64% |
| 2019 Q1 | 424.8 Million INR | 283.26% |
| 2019 FY | - INR | 51.98% |
| 2019 Q4 | 227.97 Million INR | -50.41% |
| 2018 Q4 | 110.84 Million INR | -59.9% |
| 2018 Q1 | 295.7 Million INR | -11.97% |
| 2018 Q2 | 342.3 Million INR | 15.76% |
| 2018 FY | - INR | -23.74% |
| 2018 Q3 | 276.4 Million INR | -19.25% |
| 2017 FY | - INR | 22.88% |
| 2017 Q1 | 319.2 Million INR | -4.86% |
| 2017 Q2 | 325.8 Million INR | 2.07% |
| 2017 Q3 | 321.3 Million INR | -1.38% |
| 2017 Q4 | 335.9 Million INR | 4.54% |
| 2016 Q1 | 222.4 Million INR | -13.66% |
| 2016 FY | - INR | 23.76% |
| 2016 Q4 | 335.5 Million INR | 21.12% |
| 2016 Q3 | 277 Million INR | -0.22% |
| 2016 Q2 | 277.6 Million INR | 24.82% |
| 2015 Q1 | 134.3 Million INR | -29.95% |
| 2015 Q3 | 218.3 Million INR | -9.46% |
| 2015 Q4 | 257.6 Million INR | 18.0% |
| 2015 FY | - INR | 11.56% |
| 2015 Q2 | 241.1 Million INR | 79.52% |
| 2014 FY | - INR | 103.44% |
| 2014 Q4 | 191.72 Million INR | 0.0% |
| 2014 Q1 | 189.82 Million INR | 0.0% |
| 2014 Q2 | 189.82 Million INR | 0.0% |
| 2014 Q3 | 191.72 Million INR | 1.0% |
| 2013 FY | - INR | -16.46% |
| 2012 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Apollo Hospitals Enterprise Limited | 24.02 Billion INR | 85.411% |
| Artemis Medicare Services Limited | 1.24 Billion INR | -181.256% |
| Aster DM Healthcare Limited | 6.11 Billion INR | 42.699% |
| Fortis Healthcare Limited | 13.07 Billion INR | 73.197% |
| Indraprastha Medical Corporation Limited | 2.1 Billion INR | -66.674% |
| Krishna Institute of Medical Sciences Limited | 6.61 Billion INR | 46.987% |
| Lotus Eye Hospital and Institute Limited | 79.42 Million INR | -4312.18% |
| Max Healthcare Institute Limited | 16.7 Billion INR | 79.018% |
| Max India Limited | -353.8 Million INR | 1090.478% |
| Global Health Limited | 8.71 Billion INR | 59.804% |
| Narayana Hrudayalaya Limited | 12.42 Billion INR | 71.797% |
| Rainbow Children's Medicare Limited | 4.69 Billion INR | 25.348% |
| Shalby Limited | 1.98 Billion INR | -76.942% |